Modus
is a Sweden-based biotechnology company that develops and commercializes novel therapeutics for the treatment of a range of diseases... Read moreModus
is a Sweden-based biotechnology company that develops and commercializes novel therapeutics for the treatment of a range of diseases... Read more
News
Oct 15, 2026
Manufacturing Chemist
Modus: Modus Therapeutics pauses Phase II trial after unexpected serious adverse event in patient
May 26, 2026
Marketscreener
Modus: Modus Therapeutics Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2026
Dec 10, 2025
PharmaTimes
Modus: Modus Therapeutics advances sevuparin study in chronic kidney disease with anemia
Nov 26, 2025
Marketscreener
Modus: Modus Therapeutics Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
Nov 04, 2025
StreetInsider
Press Release: Modus : Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia
May 14, 2025
Marketscreener
Modus: Modus Therapeutics Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2025
Nov 19, 2024
GlobeNewswire
Modus: Karolinska Development's portfolio company Modus Therapeutics secures bridge financing
Aug 23, 2024
Marketscreener
Modus: Modus Therapeutics Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Feb 21, 2024
Marketscreener
Modus: Modus Therapeutics Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Dec 15, 2023
FinanzNachrichten
Modus: Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Modus Therapeutics Holding AB (176/23)
Modus Competitors
1
2
3
4
5